Omega Therapeutics (OMGA) Stock Price, News & Analysis
Company Description
Omega Therapeutics (NASDAQ: OMGA) is a publicly traded biological product (except diagnostic) manufacturing company in the Biological Products, (no Disgnostic Substances) sector. The company has a market capitalization of $7.9M, ranking #6,711 among all listed U.S. companies by market cap.
OMGA stock has declined 96.4% over the past year. Shares last traded at $0.1426.
This page provides a comprehensive overview of OMGA stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Omega Therapeutics (OMGA) stock last traded at $0.1426. Over the past 12 months, the stock has lost 96.4%. At a market capitalization of $7.9M, OMGA is classified as a micro-cap stock with approximately 55.4M shares outstanding.
OMGA Rankings
Latest News
Omega Therapeutics has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include management, earnings, clinical trial, conferences. View all OMGA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
OMGA Company Profile & Sector Positioning
Omega Therapeutics (OMGA) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.